| Literature DB >> 25997728 |
Matthias M Herth1,2, Gitte M Knudsen1.
Abstract
Serotonin 2A receptors have been implicated in various psychophysiological functions and disorders such as depression, Alzheimer's disease, or schizophrenia. Therefore, neuroimaging of this specific receptor is of significant clinical interest, and it is not surprising that many attempts have been made to develop a suitable 5-HT2A R positron emission tomography-tracer. In this review, we give an overview on the precursor, reference compound synthesis, and the preparation of promising 5-HT2A R radiopharmaceuticals applied in positron emission tomography. We also highlight possible learning outcomes that can be made from these tracer development processes.Entities:
Keywords: (R)-[18F]MH.MZ; 5-HT2A; PET; [11C]Cimbi-36; [11C]MDL 100907; [18F]MDL 100907 [18F]altanserin; [18F]MH.MZ; [18F]RP62203; [18F]deuteroaltanserin; [18F]fananserin; tracer development
Mesh:
Substances:
Year: 2015 PMID: 25997728 DOI: 10.1002/jlcr.3288
Source DB: PubMed Journal: J Labelled Comp Radiopharm ISSN: 0362-4803 Impact factor: 1.921